Akar N - Search Results

1

Is tissue-plasminogen activator gene polymorphism a risk factor for venous thromboembolism in every population?

Oguzulgen IK, Ekim N, Erkekol FO, Altinok B, Akar N. Oguzulgen IK, et al. Among authors: akar n. J Thromb Thrombolysis. 2005 Feb;19(1):61-3. doi: 10.1007/s11239-005-0941-5. J Thromb Thrombolysis. 2005. PMID: 15976969

2

High plasma levels of factor VIII: an important risk factor for isolated pulmonary embolism.

Erkekol FO, Ulu A, Numanoglu N, Akar N. Erkekol FO, et al. Among authors: akar n. Respirology. 2006 Jan;11(1):70-4. doi: 10.1111/j.1440-1843.2006.00786.x. Respirology. 2006. PMID: 16423204

3

The role of plasminogen activator inhibitor-1 polymorphism, factor-V-Leiden, and prothrombin-20210 mutations in pulmonary thromboembolism.

Oguzulgen IK, Yilmaz E, Demirtas S, Erkekol FO, Ekim N, Demir N, Numanoglu N, Ozel D, Ulu A, Akar N. Oguzulgen IK, et al. Among authors: akar n. Clin Appl Thromb Hemost. 2009 Feb;15(1):73-7. doi: 10.1177/1076029607305110. Epub 2007 Dec 26. Clin Appl Thromb Hemost. 2009. PMID: 18160588 Free article.

4

The role of thrombophilic risk factors in the severity of pulmonary thromboembolism.

Oguzulgen IK, Ekim NN, Akar N, Demirel K, Kitapci M. Oguzulgen IK, et al. Among authors: akar n. Eur Respir J. 2002 Apr;19(4):709-11. doi: 10.1183/09031936.02.01472001. Eur Respir J. 2002. PMID: 11999002 Free article.

5

No relation between angiotensin-converting enzyme gene polymorphism and pseudoexfoliation.

Tekeli O, Turaçli ME, Altinok B, Akar N, Elhan AH. Tekeli O, et al. Among authors: akar n. Ophthalmic Res. 2008;40(1):32-4. doi: 10.1159/000111156. Epub 2006 Nov 27. Ophthalmic Res. 2008. PMID: 18025834

6

The role of angiotensin-converting enzyme gene polymorphism in pulmonary thromboembolism.

Ekim N, Oguzulgen IK, Demir N, Altinok B, Akar N. Ekim N, et al. Among authors: akar n. Thromb Haemost. 2004 Aug;92(2):432-3. Thromb Haemost. 2004. PMID: 15269845 No abstract available.

7

Prevalence of Factor V 1691 G-A (Leiden) and prothrombin G20210A polymorphisms and the risk of venous thrombosis among cancer patients.

Eroglu A, Ulu A, Cam R, Kurtman C, Akar N. Eroglu A, et al. Among authors: akar n. J Thromb Thrombolysis. 2007 Feb;23(1):31-4. doi: 10.1007/s11239-006-9001-z. J Thromb Thrombolysis. 2007. PMID: 17106650

8

The effect of plasminogen activator inhibitor-1 -675 4G/5G polymorphism on familial Mediterranean fever (FMF) disease.

Ozel Demiralp D, Ekim M, Akar N. Ozel Demiralp D, et al. Among authors: akar n. Clin Appl Thromb Hemost. 2009 Jul-Aug;15(4):443-7. doi: 10.1177/1076029608325540. Epub 2008 Nov 24. Clin Appl Thromb Hemost. 2009. PMID: 19033264 Free article.

9

Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in cancer patients with and without thrombosis.

Eroglu A, Ulu A, Akar N. Eroglu A, et al. Among authors: akar n. J Thromb Thrombolysis. 2006 Oct;22(2):111-2. doi: 10.1007/s11239-006-9054-z. J Thromb Thrombolysis. 2006. PMID: 17008976 No abstract available.

10

Effect of plasminogen activator inhibitor-1 4G/5G polymorphism in Turkish deep vein thrombotic patients with and without FV1691 G-A.

Akar N, Yilmaz E, Akar E, Avcu F, Yalçin A, Cin S. Akar N, et al. Among authors: akar e. Thromb Res. 2000 Feb 15;97(4):227-30. doi: 10.1016/s0049-3848(99)00164-4. Thromb Res. 2000. PMID: 10674409

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

397 results

Search Page

Filters